← All indications
Cartilage Diseases
Pathological processes involving the chondral tissue (CARTILAGE).
Subtype terms (7)
More specific conditions that are subtypes of Cartilage Diseases in the MeSH hierarchy.
- Chondromalacia Patellae
2 drugs (1 approved, 1 experimental)
- Laryngomalacia
3 drugs approved
- Osteochondritis
1 drug approved
- Pectus Carinatum
- Polychondritis, Relapsing
9 drugs (8 approved, 1 experimental)
- Tietze's Syndrome
- Tracheobronchomalacia
Drugs by status
Approved for this indication (1)
Phase 3 trials (7)
Phase 2 trials (12)
- lna043
- peripheral blood lymphocytes
- teriparatide
- ceftriaxone
- sprifermin
- umbilical cord mesenchymal stem cells
- autologous bone marrow derived mesenchymal cells
- autologous mesenchymal stem cells
- losartan
- autologous hematopoietic stem cells
- autologous adipose-derived mesenchymal stem cells
- somatic mesenchymal stromal cells
Phase 1 trials (4)
Organizations
Organization Involved with Phase 3 Indications (5)
Organization Involved with Phase 2 Indications (10)
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (2)